NCT06494995 2025-06-04AK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic TherapyFudan UniversityPhase 2 Recruiting52 enrolled
NCT03852251 2024-08-02A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ AdenocarcinomaAkesoPhase 1/2 Completed338 enrolled
NCT02735239 2024-03-22Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal CancerLudwig Institute for Cancer ResearchPhase 1/2 Completed73 enrolled 18 charts